Ticagrelor and Abrocitinib: Interaction Details
- Ticagrelor
- Brilinta
- Abrocitinib
- Cibinqo
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Ticagrelor and Abrocitinib interaction:
What Happens When You Take Ticagrelor With Abrocitinib
What can happen when they are taken together (rated Contraindicated)
Increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
During the first 3 months of abrocitinib therapy, with agents is because of a heightened bleeding risk, with the sole exception of low-dose aspirin (81 mg daily or less).1
The Ticagrelor and Abrocitinib Interaction, Explained
Taking ticagrelor (Brilinta) and abrocitinib (Cibinqo) together raises the chance of bleeding. Ticagrelor keeps from clumping, which helps prevent clots in the heart and blood vessels. Abrocitinib, used for eczema, can lower platelet counts, so the two may add up to more bleeding. This is based on how the drugs work rather than on reports of harm in patients. Even so, the labeling says this combination should not be used during the first 3 months of abrocitinib treatment.
Do not stop or change either medicine on your own, since ticagrelor protects your heart. Talk with your pharmacist or doctor, who can review your options and keep you safe.
effects on hemostasis. Ticagrelor is a reversible P2Y12 . Abrocitinib (JAK1 ) is associated with dose-related count reductions, so combined activity and may raise bleeding risk. Evidence is theoretical; no PK interaction is described. Onset is unspecified.
- Labeling: antiplatelet agents, other than low-dose aspirin (81 mg/day or less), are during the first 3 months of abrocitinib therapy.
- Management: avoid the combination in this window; consider alternative atopic dermatitis therapy or reassess the antiplatelet indication with the cardiology or prescribing team.
- Monitor for bleeding signs and platelet counts if exposure is unavoidable.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Ticagrelor and Abrocitinib Interact
The likely mechanism
effects on hemostasis
How to Manage the Ticagrelor and Abrocitinib Interaction
The documented guidance is to avoid combining abrocitinib with agents like ticagrelor (other than low-dose aspirin, 81 mg daily or less) during the first 3 months of abrocitinib treatment.
- Keep taking your medicines as prescribed until your care team advises otherwise.
- Tell your pharmacist and prescribers that you take ticagrelor before starting or if you are already on abrocitinib.
- Your team may choose a different eczema treatment or review the timing and your heart medicine plan.
- Report unusual bruising, nosebleeds, black stools, or blood in urine promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Ticagrelor or Abrocitinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Ticagrelor and Abrocitinib: Common Questions
How serious is the Ticagrelor and Abrocitinib interaction?
It is rated . These should generally not be used together.
How is the Ticagrelor and Abrocitinib interaction managed?
The documented guidance is to avoid combining abrocitinib with agents like ticagrelor (other than low-dose aspirin, 81 mg daily or less) during the first 3 months of abrocitinib treatment. Keep taking your medicines as prescribed until your care team advises otherwise. Tell your pharmacist and prescribers that you take ticagrelor before starting or if you are already on abrocitinib. Y… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Ticagrelor and Abrocitinib Interaction
Ask in your own words about taking Ticagrelor and Abrocitinib together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: CIBINQO(TM) oral tablets, abrocitinib oral tablets. Pfizer Labs (per FDA), New York, NY, 2022. DailyMed
Other Serious Interactions of Ticagrelor and Abrocitinib
Also serious with Ticagrelor
- ColchicineContraindicated
- Defibrotide InjectionContraindicated
- ItraconazoleContraindicated
- LevoketoconazoleContraindicated
Also serious with Abrocitinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Ticagrelor
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- PiracetamMajor
- Vitamin EModerate
- SeleniumModerate
- GingerModerate
- TurmericModerate
- + 285 more
With Abrocitinib
- Activated CharcoalMajor
- PiracetamMajor
- Vitamin EModerate
- SeleniumModerate
- GingerModerate
- TurmericModerate
- Green TeaModerate
- CaffeineModerate
- + 288 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together. This interaction.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.